Sethu Sankaranarayanan

2.7k citations

38 papers · 1.4k indexed · h-index 21

Neurology top 2%
- Neuroinflammation and Neurodegeneration Mechanisms 7
Physiology top 5%
- Alzheimer's disease research and treatments 18
Biological Psychiatry top 10%
Psychiatry and Mental health top 5%
- Dementia and Cognitive Impairment Research 6
Cellular and Molecular Neuroscience top 5%
- Neuroscience and Neuropharmacology Research 4
Computational Theory and Mathematics
- Computational Drug Discovery Methods 4
Ophthalmology
- Retinal Diseases and Treatments 4
Immunology
- Complement system in diseases 4
Molecular Biology
- Metabolomics and Mass Spectrometry Studies 3

Co-authors: Ted Yednock Adam J. Simon Guoxin Wu Kaj Blennow Henrik Zetterberg Michael K. Ahlijanian Jere E. Meredith Charles F. Albright
Cited by: Neurology Physiology Biological Psychiatry
Journals: Science (1 paper)Neuron (1 paper)Journal of Neuroscience (1 paper)
Partner nations: United States United Kingdom Sweden

In The Last Decade

Sethu Sankaranarayanan

36 papers receiving 1.4k citations

Peers

Countries citing papers authored by Sethu Sankaranarayanan

Since Specialization

Citations

This map shows the geographic impact of Sethu Sankaranarayanan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sethu Sankaranarayanan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sethu Sankaranarayanan more than expected).

Fields of papers citing papers by Sethu Sankaranarayanan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sethu Sankaranarayanan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sethu Sankaranarayanan. The network helps show where Sethu Sankaranarayanan may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Sethu Sankaranarayanan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Sethu Sankaranarayanan Line = papers co-authored together Sethu Sankaranarayanan links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	CSF d18:1 sphingolipid species in Parkinson disease and dementia with Lewy bodies with and without GBA1 variants npj Parkinson s Disease ·Stefanie Lerche,Isabel Wurster,Enza Maria Valente,Micol Avenali,Daniela Samaniego,Marta Martínez‐Vicente,Jorge Hernández‐Vara,Ariadna Laguna,Andrea Sturchio,Per Svenningsson,Nicholas P. France,Carrolee Barlow,Sethu Sankaranarayanan,Kathrin Brockmann	2024	0
2	Pharmacokinetic and Target Engagement Measures of ANX007, an Anti-C1q Antibody Fragment, Following Intravitreal Administration in Nonhuman Primates Investigative Ophthalmology & Visual Science ·Anita Grover,Sethu Sankaranarayanan,Vidhu Mathur,Poojan Suri,Haiyan Qiu,Yaisa Andrews‐Zwilling,Kirsten Mease,Lori K. Taylor,Ellen Cahir-McFarland,Sanjay C. Keswani,Ted Yednock	2023	8
3	Safety and Target Engagement of Complement C1q Inhibitor ANX007 in Neurodegenerative Eye Disease SHILAP Revista de lepidopterología ·Yang Sun,David Wirta,Wendy Murahashi,Vidhu Mathur,Sethu Sankaranarayanan,Lori K. Taylor,Ted Yednock,Donald S. Fong,Jeffrey L. Goldberg	2023	16
4	Inhibiting C1q Improves Compound Muscle Action Potential and Reduces Neuronal Damage in the SOD1G93A Mouse Model (P1-13.004) Neurology ·Yaisa Andrews‐Zwilling,Vidhu Mathur,Logan J. Kuhn,Sethu Sankaranarayanan,Ellen Cahir-McFarland,Ted Yednock	2022	2
5	Complement factor C1q mediates sleep spindle loss and epileptic spikes after mild brain injury Science ·Stephanie S. Holden,Fiorella C. Grandi,Oumaima Aboubakr,Bryan Higashikubo,Frances S. Cho,Andrew H. Chang,Alejandro Osorio-Forero,Allison R. Morningstar,Vidhu Mathur,Logan J. Kuhn,Poojan Suri,Sethu Sankaranarayanan,Yaisa Andrews‐Zwilling,Andrea J. Tenner,Anita Lüthi,Eleonora Aronica,M. Ryan Corces,Ted Yednock,Jeanne T. Paz	2021	73
6	Pharmacokinetics and target engagement of intravitreal administration of ANX007, an anti-C1q antibody fragment, in nonhuman primates Investigative Ophthalmology & Visual Science ·Anita Grover,Sethu Sankaranarayanan,Vidhu Mathur,Poojan Suri,Yaisa Andrews‐Zwilling,Kirsten Mease,Lori K. Taylor,Ellen Cahir-McFarland,Sanjay C. Keswani,Ted Yednock	2021	2
7	The Classical Complement Pathway Mediates Microglia-Dependent Remodeling of Spinal Motor Circuits during Development and in SMA Cell Reports ·Aleksandra Vukojicic,Nicolas Delestrée,Emily V. Fletcher,John G. Pagiazitis,Sethu Sankaranarayanan,Ted Yednock,Ben A. Barres,George Z. Mentis	2019	86
8	C1q-targeted inhibition of the classical complement pathway prevents injury in a novel mouse model of acute motor axonal neuropathy Acta Neuropathologica Communications ·Rhona McGonigal,Madeleine E. Cunningham,Denggao Yao,Jennifer A. Barrie,Sethu Sankaranarayanan,Simon Ngamli Fewou,Koichi Furukawa,Ted Yednock,Hugh J. Willison	2016	49
9	Centrally Delivered BACE1 Inhibitor Activates Microglia, and Reverses Amyloid Pathology and Cognitive Deficit in Aged Tg2576 Mice Journal of Neuroscience ·Deepak R. Thakker,Sethu Sankaranarayanan,Marcy R. Weatherspoon,Jonathan Harrison,Maria Pierdomenico,J Heisel,Lorin A. Thompson,Roy Haskell,James E. Grace,Sarah Taylor,Charles F. Albright,Lisa Shafer	2015	26
10	Tau Overexpression Impacts a Neuroinflammation Gene Expression Network Perturbed in Alzheimer’s Disease PLoS ONE ·Paul D. Wes,Amy Easton,John Corradi,Donna M. Barten,Nino Devidze,Lynn B. DeCarr,Amy Truong,Aiqing He,Nestor X. Barrezueta,Craig Polson,Clotilde Bourin,Marianne E. Flynn,Stefanie Keenan,Regina Lidge,Jere E. Meredith,JoAnne E. Natale,Sethu Sankaranarayanan,Greg Cadelina,Charlie Albright,Angela Cacace	2014	84
11	Characterization of Novel CSF Tau and ptau Biomarkers for Alzheimer’s Disease PLoS ONE ·Jere E. Meredith,Sethu Sankaranarayanan,Valerie Guss,Anthony J. Lanzetti,Flora Berisha,Robert Neely,J. Randall Slemmon,Erik Portelius,Henrik Zetterberg,Kaj Blennow,Holly Soares,Michael K. Ahlijanian,Charles F. Albright	2013	152
12	Effects of sub-chronic donepezil on brain Abeta and cognition in a mouse model of Alzheimer’s disease Psychopharmacology ·Amy Easton,Sethu Sankaranarayanan,An Tanghe,Dick Terwel,Alan Lin,Nina Hoque,Clotilde Bourin,Huidong Gu,Michael K. Ahlijanian,Linda J. Bristow	2013	30
13	Pharmacological applications of a novel neoepitope antibody to a modified amyloid precursor protein-derived beta-secretase product Protein & Cell ·Guoxin Wu,Sethu Sankaranarayanan,Donna L. Montgomery,Adam Simon,Zhiqiang An,Mary J. Savage	2011	3
14	Decrease in brain soluble amyloid precursor protein β (sAPPβ) in Alzheimer's disease cortex Journal of Neuroscience Research ·Guoxin Wu,Sethu Sankaranarayanan,Sidney Hsieh,Adam J. Simon,Mary J. Savage	2011	26
15	Viable mouse gene ablations that robustly alter brain Aβ levels are rare BMC Neuroscience ·Jeremy H. Toyn,Xu-Alan Lin,Mark Thompson,Valerie Guss,Jere E. Meredith,Sethu Sankaranarayanan,Nestor X. Barrezueta,John Corradi,Antara Majumdar,Daniel L. Small,Melissa Hansard,Thomas H. Lanthorn,Ryan S. Westphal,Charles F. Albright	2010	8
16	Elevated Cerebrospinal Fluid BACE1 Activity in Incipient Alzheimer Disease Archives of Neurology ·Henrik Zetterberg,Ulf Andréasson,Oskar Hansson,Guoxin Wu,Sethu Sankaranarayanan,Malin E. Andersson,Peder Buchhave,Elisabet Londos,Robert M. Umek,Lennart Minthon,Adam J. Simon,Kaj Blennow	2008	182
17	In Vivo β-Secretase 1 Inhibition Leads to Brain Aβ Lowering and Increased α-Secretase Processing of Amyloid Precursor Protein without Effect on Neuregulin-1 Journal of Pharmacology and Experimental Therapeutics ·Sethu Sankaranarayanan,Eric A. Price,Guoxin Wu,Ming‐Chih Crouthamel,Xiao‐Ping Shi,Katherine Tugusheva,Keala X. Tyler,Jason A. Kahana,Joan D. Ellis,Lixia Jin,Thomas G. Steele,Shawn J. Stachel,Craig A. Coburn,Adam J. Simon	2007	83
18	Strategies toward improving the brain penetration of macrocyclic tertiary carbinamine BACE-1 inhibitors Bioorganic & Medicinal Chemistry Letters ·Keith P. Moore,Hong Zhu,Hemaka A. Rajapakse,Georgia B. McGaughey,Dennis Colussi,Eric A. Price,Sethu Sankaranarayanan,Adam Simon,Nicole T. Pudvah,Jerome Hochman,Timothy J. Allison,Sanjeev Munshi,Samuel Graham,Joseph P. Vacca,Philippe G. Nantermet	2007	29
19	Genetically Modified Mice Models for Alzheimers Disease Current Topics in Medicinal Chemistry ·Sethu Sankaranarayanan	2006	9
20	Regulation of Gene Expression by Lithium and Depletion of Inositol in Slices of Adult Rat Cortex Neuron ·Philip E. Brandish,Ming Su,Daniel Holder,Paul Hodor,John Szumiloski,Robert Kleinhanz,Jaime E. Forbes,Mollie E. McWhorter,Sven Duenwald,Mark L Parrish,Na Sang,Yuan Liu,Robert L. Phillips,John J. Renger,Sethu Sankaranarayanan,Adam J. Simon,Edward M. Scolnick	2005	69

About Sethu Sankaranarayanan

Sethu Sankaranarayanan is a scholar working on Neurology, Physiology and Psychiatry and Mental health, having authored 38 papers that have together received 1.4k indexed citations. Recurring topics across this work include Alzheimer's disease research and treatments (18 papers), Neuroinflammation and Neurodegeneration Mechanisms (7 papers), Dementia and Cognitive Impairment Research (6 papers), Neuroscience and Neuropharmacology Research (4 papers), Computational Drug Discovery Methods (4 papers), Retinal Diseases and Treatments (4 papers), Complement system in diseases (4 papers) and Metabolomics and Mass Spectrometry Studies (3 papers). The work is most often cited by research in Neurology (312 citations), Physiology (764 citations) and Biological Psychiatry (46 citations). Sethu Sankaranarayanan has collaborated with scholars based in United States, United Kingdom and Sweden. Frequent co-authors include Ted Yednock, Adam J. Simon, Guoxin Wu, Kaj Blennow, Henrik Zetterberg, Michael K. Ahlijanian, Jere E. Meredith, Charles F. Albright, Valerie Guss and Haiyan Qiu. Their work appears in journals such as Science, Neuron and Journal of Neuroscience.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact